• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长非编码 RNA 作为一种新型的癌细胞免疫反应调控因子的调控作用。

The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.

机构信息

Molecular Biology and Virology lab, Biomedical Sciences Program, UST, Zewail City of Science and Technology, October Gardens, 6th of October City, 12578, Giza, Egypt.

Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt.

出版信息

Mol Biol Rep. 2022 Dec;49(12):11775-11793. doi: 10.1007/s11033-022-07947-4. Epub 2022 Oct 7.

DOI:10.1007/s11033-022-07947-4
PMID:36207500
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9712323/
Abstract

Immunotherapy has been established as a promising therapy for different cancer types. However, many patients experience primary or secondary resistance to treatment. Immune cells and anti-inflammatory factors are regulated by long noncoding RNAs (lncRNAs). In addition, lncRNAs have a role in immune resistance through antigen presentation loss or attenuation, PD-L1 upregulation, loss of T-cell activities, and activation of G-MDSCs and Tregs in the tumor environment. LncRNAs can also influence the interaction between cancer stem cells and immune cells in the tumor microenvironment, potentially resulting in cancer stem cell resistance to immunotherapy. Immunological-related lncRNAs can influence immune responses either directly by affecting neighboring protein-coding genes or indirectly by sponging miRNAs through various mechanisms. We have emphasized the role and levels of expression of lncRNAs that have been linked to immune cell formation, differentiation, and activation, which may have an influence on immunotherapy efficacy.

摘要

免疫疗法已被确立为治疗不同癌症类型的一种有前途的疗法。然而,许多患者对治疗产生原发性或继发性耐药。免疫细胞和抗炎因子受长链非编码 RNA(lncRNA)的调节。此外,lncRNA 通过抗原呈递损失或减弱、PD-L1 上调、T 细胞活性丧失以及肿瘤微环境中 G-MDSCs 和 Tregs 的激活,在免疫抵抗中发挥作用。lncRNA 还可以影响肿瘤微环境中癌症干细胞与免疫细胞之间的相互作用,从而导致癌症干细胞对免疫疗法产生耐药性。免疫相关 lncRNA 可以通过直接影响邻近的蛋白编码基因或通过通过各种机制与 miRNAs 结合,从而间接影响免疫反应。我们强调了与免疫细胞形成、分化和激活相关的 lncRNA 的作用和表达水平,这些可能对免疫治疗的疗效有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/6d08434c8a1e/11033_2022_7947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/cfe96d0fa55c/11033_2022_7947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/b0f7f2402358/11033_2022_7947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/6d08434c8a1e/11033_2022_7947_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/cfe96d0fa55c/11033_2022_7947_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/b0f7f2402358/11033_2022_7947_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ec4/9712323/6d08434c8a1e/11033_2022_7947_Fig3_HTML.jpg

相似文献

1
The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.长非编码 RNA 作为一种新型的癌细胞免疫反应调控因子的调控作用。
Mol Biol Rep. 2022 Dec;49(12):11775-11793. doi: 10.1007/s11033-022-07947-4. Epub 2022 Oct 7.
2
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.长非编码 RNA 在癌症免疫监视和免疫治疗中的反应和耐药性。
Cells. 2021 Nov 26;10(12):3313. doi: 10.3390/cells10123313.
3
PD-1/PD-L1 axis regulation in cancer therapy: The role of long non-coding RNAs and microRNAs.PD-1/PD-L1 轴在癌症治疗中的调控:长非编码 RNA 和 microRNA 的作用。
Life Sci. 2020 Sep 1;256:117899. doi: 10.1016/j.lfs.2020.117899. Epub 2020 Jun 3.
4
Noncoding RNAs as novel immunotherapeutic tools against cancer.非编码RNA作为新型抗癌免疫治疗工具
Adv Protein Chem Struct Biol. 2022;129:135-161. doi: 10.1016/bs.apcsb.2021.11.011. Epub 2022 Jan 11.
5
Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.长链非编码 RNA 与肿瘤免疫微环境:生物学特性与治疗潜能
Front Immunol. 2021 Jul 6;12:697083. doi: 10.3389/fimmu.2021.697083. eCollection 2021.
6
Long noncoding RNAs in cancer-immunity cycle.长链非编码 RNA 在癌症-免疫循环中的作用。
J Cell Physiol. 2018 Sep;233(9):6518-6523. doi: 10.1002/jcp.26568. Epub 2018 Mar 25.
7
Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review.探索长链非编码 RNA 在癌症免疫治疗中的潜在作用:全面综述。
Front Immunol. 2024 Aug 27;15:1446937. doi: 10.3389/fimmu.2024.1446937. eCollection 2024.
8
Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application.非编码 RNA 在癌症免疫中的作用:功能、调控机制及临床应用。
Mol Cancer. 2020 Mar 2;19(1):48. doi: 10.1186/s12943-020-01154-0.
9
Non-coding RNA in tumor-infiltrating regulatory T cells formation and associated immunotherapy.肿瘤浸润调节性 T 细胞形成及相关免疫治疗中的非编码 RNA。
Front Immunol. 2023 Aug 21;14:1228331. doi: 10.3389/fimmu.2023.1228331. eCollection 2023.
10
Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.胃癌中 m6A 相关 lncRNAs 的肿瘤免疫微环境综合分析与预后评估。
BMC Cancer. 2022 Mar 24;22(1):316. doi: 10.1186/s12885-022-09377-8.

引用本文的文献

1
Liquid biopsy in TNBC: significance in diagnostics, prediction, and treatment monitoring.三阴性乳腺癌中的液体活检:在诊断、预测和治疗监测中的意义
Front Oncol. 2025 Aug 4;15:1607960. doi: 10.3389/fonc.2025.1607960. eCollection 2025.
2
LncRNAs as behind-the-scenes molecules in cancer progression through regulating tumor-associated innate immune system cells.长链非编码RNA作为癌症进展中的幕后分子,通过调节肿瘤相关固有免疫系统细胞发挥作用。
Mol Biol Rep. 2025 May 8;52(1):449. doi: 10.1007/s11033-025-10513-3.
3
Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer.

本文引用的文献

1
Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.长非编码 RNA 在癌症免疫监视和免疫治疗中的反应和耐药性。
Cells. 2021 Nov 26;10(12):3313. doi: 10.3390/cells10123313.
2
Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers.癌症干细胞:癌症免疫逃逸中新兴的关键角色。
Front Cell Dev Biol. 2021 Jun 21;9:692940. doi: 10.3389/fcell.2021.692940. eCollection 2021.
3
Gene regulation by long non-coding RNAs and its biological functions.长非编码 RNA 的基因调控及其生物学功能。
肿瘤微环境重塑:克服三阴性乳腺癌治疗耐药性及创新免疫工程的策略
Front Immunol. 2024 Dec 10;15:1455211. doi: 10.3389/fimmu.2024.1455211. eCollection 2024.
4
lncRNAs'p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer.lncRNAs 在癌症发病机制中的潜在作用,通过与信号通路相互作用;特别关注 lncRNA 介导的肺癌信号失调。
Med Oncol. 2024 Nov 8;41(12):310. doi: 10.1007/s12032-024-02536-w.
5
Exploring potential roles of long non-coding RNAs in cancer immunotherapy: a comprehensive review.探索长链非编码 RNA 在癌症免疫治疗中的潜在作用:全面综述。
Front Immunol. 2024 Aug 27;15:1446937. doi: 10.3389/fimmu.2024.1446937. eCollection 2024.
6
The role of HOTAIR in the modulation of resistance to anticancer therapy.HOTAIR在调节抗癌治疗耐药性中的作用。
Front Mol Biosci. 2024 Jun 3;11:1414651. doi: 10.3389/fmolb.2024.1414651. eCollection 2024.
7
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways.癌症耐药中的长链非编码RNA-微小RNA轴:特别关注信号通路
Med Oncol. 2024 Jan 9;41(2):52. doi: 10.1007/s12032-023-02263-8.
8
The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applications.胃癌中长链非编码RNA的研究现状:从分子机制到潜在临床应用
Front Pharmacol. 2023 Aug 21;14:1237723. doi: 10.3389/fphar.2023.1237723. eCollection 2023.
9
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer.三阴性乳腺癌中长链非编码 RNA 的最新临床进展
Cells. 2023 Feb 20;12(4):674. doi: 10.3390/cells12040674.
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118. doi: 10.1038/s41580-020-00315-9. Epub 2020 Dec 22.
4
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.肿瘤微环境中的癌症干细胞分泌组:实现有效个体化癌症治疗的关键点。
J Hematol Oncol. 2020 Oct 15;13(1):136. doi: 10.1186/s13045-020-00966-3.
5
The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer.髓系来源的抑制性细胞在增加上皮性卵巢癌中癌症干细胞样细胞和促进 PD-L1 表达中的作用。
Cancer Immunol Immunother. 2020 Dec;69(12):2477-2499. doi: 10.1007/s00262-020-02628-2. Epub 2020 Jun 19.
6
Corrigendum: Coagulation Factor X Regulated by CASC2c Recruited Macrophages and Induced M2 Polarization in Glioblastoma Multiforme.勘误:由CASC2c调控的凝血因子X招募巨噬细胞并诱导多形性胶质母细胞瘤中的M2极化。
Front Immunol. 2020 May 29;11:934. doi: 10.3389/fimmu.2020.00934. eCollection 2020.
7
Long non-coding RNA GAS5 promotes natural killer cell cytotoxicity against gastric cancer by regulating miR-18a.长链非编码 RNA GAS5 通过调节 miR-18a 促进自然杀伤细胞对胃癌的细胞毒性。
Neoplasma. 2020 Sep;67(5):1085-1093. doi: 10.4149/neo_2020_191014N1034. Epub 2020 Jun 16.
8
An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients.免疫相关长链非编码 RNA 标志物预测胶质瘤患者的生存情况。
Cell Mol Neurobiol. 2021 Mar;41(2):365-375. doi: 10.1007/s10571-020-00857-8. Epub 2020 May 14.
9
Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.下调的 M2 巨噬细胞来源的外泌体中的 lncRNA SBF2-AS1 上调 miR-122-5p 以限制 XIAP,从而限制胰腺癌的发展。
J Cell Mol Med. 2020 May;24(9):5028-5038. doi: 10.1111/jcmm.15125. Epub 2020 Apr 16.
10
Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer.长非编码 RNA 生物标志物与癌症患者临床免疫亚型的关联及其对免疫治疗反应的预测。
JAMA Netw Open. 2020 Apr 1;3(4):e202149. doi: 10.1001/jamanetworkopen.2020.2149.